Synklino
Biotechnology ResearchView the employees at
Synklino-
Fredrika Carlsson Project Director på Synklino
-
Lund, Kalmar County, Sweden
-
Rising Star
Joachim Breitenstein Stud. MEng. Bioinformatics & Systems biology at DTU | Student Assistant at Synklino-
Copenhagen, Capital Region, Denmark
-
Rising Star
Romain LALANDES BD Executive - Biotech-
Rising Star
Jette Wagtberg Sen Chief Operating Officer at Synklino-
Copenhagen Metropolitan Area
-
Top 10%
Marie Juhl Finance Manager, Synklino A/S-
Copenhagen, Capital Region, Denmark
-
Rising Star
Overview
Synklino strives to provide rapid relief as well as to improve long-term survival for transplant recipients by providing fast and safe eradication of cytomegalovirus (CMV) infections. For transplant recipients, CMV disease causes suboptimal transplantation outcome, increased morbidity, prolonged hospitalization and increased mortality. Our drug candidate SYN002 efficiently eliminates both lytic as well as latently infected cells, and thereby potently inhibits viral replication and eradicates the virus - simply taking CMV out of the equation for the transplant recipient. SYN002 highly potently, efficiently and selectively eliminates CMV infected cells through a proven mechanism, allowing for both stand-alone and combination therapy.
-